Search bioRxiv⌕ Search

Biology subjects

Li, A.-H.

Publications and source records attributed to Li, A.-H..

2 recordsLinked to original sources

Proposal of two new genera and seventy-seven new species of ascomycetous yeasts isolated from China

Ascomycetous yeasts belong to Saccharomycotina and Taphrinomycotina, with about 1,200 described species distributed worldwide. More than 300 ascomycetous yeast species have been reported from China, which indicates that China possesses a hotspot with high yeast diversity. However, our knowledge of yeast diversity and distribution remains limited, and this area needs to be explored in depth. Here we describe 77 new ascomycetous yeast species with 195 isolates obtained over the past two decades during the continuous yeast diversity surveys in China, based on the phylogenetic analyses of the sequences of D1/D2 domains of the large subunit (LSU) and the internal transcribed spacer region including the 5.8S rDNA (ITS) of the nuclear ribosomal DNA (rDNA). The average nucleotide identity (ANI) analysis was used to delimitate closely related species with low sequence heterogeneity in the ITS and D1/D2 regions. Seventy-five of these new species belong to 35 genera in the Saccharaomycotina, while the other two are distributed in Taphrina of the Taphrinomycotina. In addition, we propose two new genera, namely Gaboromyces gen. nov. and Yurkovozyma gen. nov.

microbiology↗

A single dose of intravenous human amniotic membrane-derived mesenchymal stem cells limits transmural infarction, reduces fibrosis size, and improves left ventricular systolic function in the myocardial ischemic/reperfusion model of rats

Despite the advances in coronary reperfusion in acute myocardial infarction (MI), post-MI heart failure is still a large burden of public health. Transmural infarction and extended fibrosis contribute largely to post-MI systolic dysfunction and heart failure, and thus cardioprotective strategies are crucial. Human amniotic membrane-derived mesenchymal stem cells (hAMSCs) have been shown with properties of immunomodulation, anti-inflammation, and low immunogenicity, which make them good candidates for cell therapies. In this study, a myocardial ischemia/reperfusion (I/R) model was established in rats, and hAMSCs were administered via the tail vein during coronary reperfusion. Compared to the control group, the rats receiving hAMSCs during the I/R procedure (hAMSC group) exhibited significantly better left ventricular ejection fractions after MI. Histological examinations of the hearts in hAMSC group showed minimal transmural infarction 4 weeks after the I/R procedure. Compared to the control group, hAMSC group had reduced size of cardiac fibrosis and less thinning of myocardial wall. In conclusion, intravenous hAMSCs limit transmural infarction, reduce fibrosis size, and improve left ventricular systolic function after MI in the animal model.

cell biology↗